Relationship between Cyst Fluid Concentrations of Iron and Severity of Dysmenorrhea in Patients with Ovarian Endometrioma
article
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
This study found a positive correlation between higher total and heme iron concentrations in ovarian endometrioma cyst fluid and increased dysmenorrhea severity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVES AND DESIGN: Endometriosis-related pain can be caused by anatomical distortions as well as environmental factors such as inflammation and oxidative stress. The aim of this study is to investigate the relationship between the severity of dysmenorrhea in patients with ovarian endometrioma (OMA) and cyst fluid (CF) concentrations of irons, including total iron, heme iron, and free iron. METHOD: Eighty-three patients who were histologically diagnosed with OMA were enrolled in the Department of Gynecology, Nara Medical University Hospital, between 2013 and 2019. The patients were divided into 4 groups according to the severity of dysmenorrhea: no pain, mild, moderate, and severe. Iron concentration was measured by the inductively coupled plasma optical emission spectrometry method. RESULTS: There were no significant differences among the 4 groups in variables such as age at diagnosis, preoperative CA125, preoperative CA19-9, cyst size, and tumor laterality (unilateral or bilateral). There was a positive correlation between the severity of dysmenorrhea and total iron (p < 0.001) and heme iron (p = 0.016) concentrations. Multiple regression analyses revealed that the CF concentration of total iron (hazard ratio 18.75, 95% confidence interval: 2.26-155.35, p = 0.007) was a significant independent variable associated with the severity of dysmenorrhea. A receiver operating characteristic curve analysis showed that a total iron exceeding 290.8 mg/L was associated with severe dysmenorrhea with a sensitivity of 90.9% and a specificity of 65.7%. LIMITATIONS: This study excluded patients with adenomyosis, superficial endometriosis, or deep endometriosis, resulting in a smaller number of cases. Iron levels could not be compared to the endometriosis stage using the r-ASRM score. CONCLUSIONS: There is no clear evidence that iron predicts the severity of endometriosis-related pain. However, iron may be closely associated with dysmenorrhea.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients via openalex
- Correlation between endometriosis and pelvic pain via openalex
- Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology via openalex
- Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts via openalex
- Differences in 25-hydroxy vitamin D and vitamin D-binding protein concentrations according to the severity of endometriosis via openalex
- Endometriosis-associated dysmenorrhea is not related to typical or atypical peritoneal implants via openalex
- Endometriosis Gene Expression Heterogeneity and Biosignature: A Phylogenetic Analysis via openalex
- Estrogen is an important mediator of mast cell activation in ovarian endometriomas via openalex
- Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants via openalex
- Imaging modalities for the non-invasive diagnosis of endometriosis via openalex
- Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence via openalex
- Mast cells in endometriosis: guilty or innocent bystanders? via openalex
- Modern approaches to noninvasive diagnosis of malignant transformation of endometriosis via openalex
- New therapeutic approaches for endometriosis besides hormonal therapy via openalex
- Oxidation-sensitive nociception involved in endometriosis-associated pain via openalex
- Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation via openalex
- Pathogenesis of endometriosis: the genetic/epigenetic theory via openalex
- Pathogenetic Mechanisms of Deep Infiltrating Endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Perineural invasion in endometriotic lesions contributes to endometriosis-associated pain via openalex
- Peripheral changes in endometriosis-associated pain via openalex
- PPAR-γ expression in peritoneal endometriotic lesions correlates with pain experienced by patients via openalex
- Progesterone Resistance in Endometriosis: an Acquired Property? via openalex
- Redox regulation of microRNAs in endometriosis-associated pain via openalex
- Relation between severity of dysmenorrhea and endometrioma via openalex
- Targeting oxidative stress to treat endometriosis via openalex
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights via openalex
- The role of iron in the pathogenesis of endometriosis via openalex
- Transverse Relaxation Rate of Cyst Fluid Can Predict Malignant Transformation of Ovarian Endometriosis via openalex
- W1186911639 via openalex
- W2027404967 via openalex
- W2019805616 via openalex
- W2001055223 via openalex
- W2401134385 via openalex
- W2596152408 via openalex
- W1661158834 via openalex
- W2938892895 via openalex
- W2029502252 via openalex
Cited by (10)
- Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493 2025
- Ferroptosis: a novel pathway in the pathogenesis and treatment of endometriosis 2025
- Heme metabolism and HO‐1 in the pathogenesis and potential intervention of endometriosis 2024
- Clinical characteristics of endometrioma with and without dysmenorrhea diagnosed by laparoscopy: A retrospective cohort study in a tertiary center 2024
- How Can Selected Dietary Ingredients Influence the Development and Progression of Endometriosis? 2024
- The role of iron in the pathogenesis of endometriosis: a systematic review 2023
- Serum <scp>CA125</scp> as a biomarker for dysmenorrhea in adenomyosis 2023
- Iron deposition in ovarian endometriosis evaluated by magnetic resonance imaging R2* correlates with ovarian function 2023
- Visible and near‑infrared interactance spectroscopy is a non‑invasive technique which can be used to evaluate the hemoglobin concentration in endometriotic cyst fluid 2023
- Effects of iron-related compounds and bilirubin on redox homeostasis in endometriosis and its malignant transformations 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:43.494969+00:00
License: CC0
· commercial use OK